Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyruvate dehydrogenase phosphatase regulatory subunit (PDPR) is the regulatory subunit of the mitochondrial pyruvate dehydrogenase phosphatase (PDP) complex, which dephosphorylates and activates the pyruvate dehydrogenase (PDH) complex[1][2][3][4]. PDPR is a flavoprotein that modulates the catalytic activity of PDP1 by decreasing its sensitivity to magnesium ions, a regulation that can be reversed by the polyamine spermine[1][3]. PDPR thereby plays a critical role in controlling the entry of glycolytic carbon into the tricarboxylic acid (TCA) cycle and fatty acid synthesis, linking the regulation of glucose metabolism to mitochondrial energy production[1][2][3][4]. PDPR gene variants have been implicated in rare familial phenotypes of limb-girdle muscular dystrophy and papillary thyroid cancer, where loss-of-function leads to metabolic dysregulation and may contribute to tumorigenesis[3][4]. While its precise mechanism in disease remains under investigation, available data support a possible tumor suppressor function for PDPR in glucose metabolism–dependent tissues[4]. PDPR is not currently considered a therapeutic target, and no drugs are known to modulate its function directly[3][4]. Key attributes: - FAD-containing mitochondrial regulatory protein[1][3] - Controls the reactivation of PDH by enabling PDP to dephosphorylate E1α subunit[2][4] - Regulates carbohydrate oxidation and mitochondrial energy flux[1][3] - Loss associated with enhanced phosphorylation of PDH, impaired mitochondrial function, and increased aerobic glycolysis in tumor cells[4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate dehydrogenase phosphatase regulatory subunit (PDPR).